Biliary Atresia clinical trials at UCSF
3 in progress, 0 open to eligible people
Odevixibat in Children With Biliary Atresia Who Have Undergone a Kasai HPE (BOLD)
Sorry, in progress, not accepting new patients
Double-blind, randomized, placebo-controlled, Phase 3 study to investigate the efficacy and safety of odevixibat compared to placebo in children with biliary atresia who have undergone a Kasai hepatoportoenterostomy.
San Francisco, California and other locations
Database of Infants With Cholestasis
Sorry, not currently recruiting here
Biliary atresia, idiopathic neonatal hepatitis, and specific genetic cholestatic conditions are the most common causes of jaundice and hyperbilirubinemia that continue beyond the newborn period. The long term goal of the Childhood Liver Disease Research Network (ChiLDReN) is to establish a database of clinical information and plasma, serum, and tissue samples from cholestatic children to facilitate research and to perform clinical, epidemiological and therapeutic trials in these important pediatric liver diseases.
San Francisco, California and other locations
Biliary Atresia Study in Infants and Children
Sorry, not currently recruiting here
Little is known about the factors that cause biliary atresia nor the factors that influence disease progression. The purpose of this study is to collect the pertinent clinical information, genetic material and body fluid samples to enable investigators to address the following aims: To identify the gene or genes implicated in the etiology of BA; To identify polymorphisms that may be important in disease progression such as HLA polymorphisms; To characterize the natural history of the older, non-transplanted child with BA.
San Francisco, California and other locations
Last updated: